Health Care [ 2/12 ] | Health Care Equipment & Supplies [ 12/74 ]
NASDAQ | Common Stock
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers.
The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity.
The company was founded in 1998 and is headquartered in Andover, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 3, 26 | 0.44 Decreased by -52.17% | 0.50 Decreased by -12.00% |
| May 4, 26 | 0.30 Decreased by -57.14% | 0.61 Decreased by -50.82% |
| Feb 23, 26 | 0.05 Decreased by -73.16% | 0.39 Decreased by -86.94% |
| Oct 28, 25 | 0.66 Increased by +450.00% | 0.36 Increased by +83.33% |
| Jul 29, 25 | 0.92 Increased by +162.86% | 0.43 Increased by +113.95% |
| May 7, 25 | 0.70 Increased by +100.00% | 0.24 Increased by +191.67% |
| Feb 23, 25 | 0.19 Increased by +58.33% | 0.22 Decreased by -13.64% |
| Oct 27, 24 | 0.12 Increased by +71.43% | 0.32 Decreased by -62.50% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 29, 26 | 189.95 M Increased by +20.70% | 14.68 M Decreased by -57.94% | Increased by +7.73% Decreased by -65.15% |
| Mar 30, 26 | 173.93 M Increased by +21.18% | 7.32 M Decreased by -71.52% | Increased by +4.21% Decreased by -76.49% |
| Dec 30, 25 | 160.76 M Increased by +32.18% | 105.38 M Increased by +1.44 K% | Increased by +65.55% Increased by +1.06 K% |
| Sep 29, 25 | 143.82 M Increased by +32.24% | 24.32 M Increased by +476.83% | Increased by +16.91% Increased by +336.20% |
| Jun 29, 25 | 157.37 M Increased by +37.68% | 34.91 M Increased by +186.26% | Increased by +22.18% Increased by +107.93% |
| Mar 30, 25 | 143.54 M Increased by +48.21% | 25.68 M Increased by +110.56% | Increased by +17.89% Increased by +42.07% |
| Dec 30, 24 | 121.62 M Increased by +49.83% | 6.86 M Increased by +70.11% | Increased by +5.64% Increased by +13.53% |
| Sep 29, 24 | 108.76 M Increased by +63.72% | 4.22 M Increased by +116.58% | Increased by +3.88% Increased by +110.13% |